MedTrace Logo

Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors

NCT03990025 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-02-15

No results posted yet for this study

Summary

This study aims to examine the use of Linked Color Imaging in detection of gastric cancer precursors, as well as oesophageal and duodenal lesions.

Conditions

  • Early Gastric Cancer
  • Barrett Esophagus

Interventions

DIAGNOSTIC_TEST

Linked Color Imaging

Linked Color Imaging (LCI) is a form of image enhanced endoscopy that uses a laser endoscopic system that acquires images by simultaneously using narrow-band wavelength light and white light in an appropriate balance. This enhances slight color differences in the red region of the mucosa.

DIAGNOSTIC_TEST

White Light Imaging

White Light Imaging (WLI) uses conventional white light that encompasses all bandwidths of light to illuminate areas of interest to obtain endoscopic images.

Sponsors & Collaborators

  • Singapore General Hospital

    collaborator OTHER

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • Tiing Leong Ang, MBBS · Changi General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-27
Primary Completion
2020-10-17
Completion
2020-10-17

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03990025 on ClinicalTrials.gov